Cary Street Partners Investment Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Sell |
3,131
-47
| -1% | -$3.28K | 0.11% | 219 |
|
|
2025
Q1 | $234K | Buy |
3,178
+841
| +36% | +$61.8K | 0.13% | 184 |
|
|
2024
Q4 | $153K | Sell |
2,337
-6,241
| -73% | -$409K | 0.1% | 220 |
|
|
2024
Q3 | $668K | Sell |
8,578
-53
| -0.6% | -$4.13K | 0.02% | 439 |
|
|
2024
Q2 | $673K | Buy |
8,631
+623
| +8% | +$48.6K | 0.03% | 406 |
|
|
2024
Q1 | $543K | Buy |
8,008
+353
| +5% | +$23.9K | 0.02% | 445 |
|
|
2023
Q4 | $516K | Buy |
7,655
+181
| +2% | +$12.2K | 0.02% | 421 |
|
|
2023
Q3 | $506K | Buy |
7,474
+2,046
| +38% | +$139K | 0.03% | 397 |
|
|
2023
Q2 | $388K | Hold |
5,428
| – | – | 0.03% | 398 |
|
|
2023
Q1 | $377K | Buy |
5,428
+2
| +0% | +$139 | 0.03% | 377 |
|
|
2022
Q4 | $368K | Sell |
5,426
-694
| -11% | -$47.1K | 0.03% | 375 |
|
|
2022
Q3 | $336K | Sell |
6,120
-728
| -11% | -$40K | 0.03% | 372 |
|
|
2022
Q2 | $452K | Buy |
+6,848
| New | +$452K | 0.04% | 309 |
|
|
2021
Q1 | – | Sell |
-6,799
| Closed | -$340K | – | 318 |
|
|
2020
Q4 | $340K | Buy |
6,799
+6,649
| +4,433% | +$332K | 0.07% | 237 |
|
|
2020
Q3 | $8K | Buy |
+150
| New | +$8K | ﹤0.01% | 784 |
|